The experience of blood glucose monitoring in people with type 2 diabetes mellitus (T2DM)

被引:3
|
作者
Stedman, Mike [1 ]
Rea, Rustam [2 ]
Duff, Christopher J. [3 ,4 ]
Livingston, Mark [5 ]
McLoughlin, Katie [6 ]
Wong, Louise [6 ]
Brown, Stephen [6 ]
Grady, Katherine [6 ]
Gadsby, Roger [7 ]
Gibson, John M. [6 ,8 ,9 ]
Paisley, Angela [6 ]
Fryer, Anthony A. [3 ,4 ]
Heald, Adrian H. [6 ,8 ,9 ]
机构
[1] Res Consortium, Andover, England
[2] Oxford Ctr Diabet Endocrinol & Metab, Oxford, England
[3] Univ Hosp North Midlands NHS Trust, North Midlands & Cheshire Pathol Serv, Dept Clin Biochem, Stoke On Trent, Staffs, England
[4] Keele Univ, Sch Med, Keele, Staffs, England
[5] Walsall Manor Hosp, Black Country Pathol Serv, Walsall, W Midlands, England
[6] Salford Royal Hosp, Salford, Lancs, England
[7] Univ Warwick, Warwick Med Sch, Warwick, W Midlands, England
[8] Univ Manchester, Sch Med, Manchester, Lancs, England
[9] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England
关键词
blood glucose; diabetes education; HbA1c; monitoring; patient experience; type; 2; diabetes; GLYCATED HEMOGLOBIN;
D O I
10.1002/edm2.302
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Finger prick blood glucose (BG) monitoring remains a mainstay of management in people with type 2 diabetes (T2DM) who take sulphonylurea (SU) drugs or insulin. We recently examined patient experience of BG monitoring in people with type 1 diabetes (T1DM). There has not been any recent comprehensive assessment of the performance of BG monitoring strips or the patient experience of BG strips in people with T2DM in the UK. Methods An online self-reported questionnaire containing 44 questions, prepared following consultation with clinicians and patients, was circulated to people with T2DM. 186 responders provided completed responses (25.5% return rate). Fixed responses were coded numerically (eg not confident = 0 fairly confident = 1). Results Of responders, 84% were treated with insulin in addition to other agents. 75% reported having had an HbA1c check in the previous 6 months. For those with reported HbA1c >= 65 mmol/mol, a majority of people (70%) were concerned or really concerned about the shorter term consequences of running a high HbA1c This contrasted with those who did not know their recent HbA1c, of whom only 33% were concerned/really concerned and those with HbA1c <65 mmol/mol of whom 35% were concerned. Regarding BG monitoring/insulin adjustment, only 25% of responders reported having sufficient information with 13% believing that the accuracy and precision of their BG metre was being independently checked. Only 9% recalled discussing BG metre accuracy when their latest metre was provided and only 7% were aware of the International Standardisation Organisation (ISO) standards for BG metres. 77% did not recall discussing BG metre performance with a healthcare professional. Conclusion The group surveyed comprised engaged people with T2DM but even within this group there was significant variation in (a) awareness of shorter term risks, (b) confidence in their ability to implement appropriate insulin dosage (c) awareness of the limitations of BG monitoring technology. There is clearly an area where changes in education/support would benefit many.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Blood Glucose Lowering Effects of Dextromethorphan in People with Type 2 Diabetes Mellitus (T2DM)
    Stirban, Alin
    Marquard, Jan
    Wnendt, Stephan
    Herebian, Diran
    Schliess, Freimut
    Heise, Tim
    Lammert, Eckhard
    [J]. DIABETES, 2014, 63 : A275 - A275
  • [2] Health poverty among people with type 2 diabetes mellitus (T2DM) in Malaysia
    Parra-Mujica, Fiorella
    Roope, Laurence S. J.
    Abdul-Aziz, Alia
    Mustapha, Feisul
    Ng, Chiu Wan
    Rampal, Sanjay
    Lim, Lee-Ling
    Dakin, Helen
    Clarke, Philip
    [J]. SOCIAL SCIENCE & MEDICINE, 2024, 340
  • [3] Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
    Luo, Jian-Quan
    Shu, Yan
    Zhang, Wei
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [4] Vascular responsiveness in type 2 diabetes mellitus (T2DM)
    Blum, A.
    Socea, D.
    Sirchan, R.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2016, 109 (12) : 791 - 796
  • [5] The platelets characteristics in type 2 diabetes mellitus (T2DM)
    Buryachkovskaya, L.
    Uchitel, I. A.
    Sumarokov, A. B.
    Docenko, U., V
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 931 - 931
  • [6] Microvascular complications in type 2 diabetes mellitus (T2DM).
    Cheung, AT
    Ramanujam, S
    Duong, PL
    Schauer, D
    Chan, LS
    Dwyre, DM
    Larkin, EC
    [J]. FASEB JOURNAL, 2002, 16 (04): : A208 - A208
  • [7] Colesevelam HCl reduces postprandial glucose in patients with type 2 diabetes mellitus (T2DM)
    Zieve, Franklin
    Schwartz, Sherwyn L.
    Kalin, Marcia
    Jones, Michael R.
    [J]. DIABETES, 2006, 55 : A140 - A140
  • [8] Safety and Effectiveness of iGlarLixi in People with Type 2 Diabetes Mellitus (T2DM) in South Korea
    Kim, Hun-Sung
    Min, Kyungwan
    Kim, Sang Soo
    Kim, Eun Sook
    Chung, Yoon-Sok
    Chung, Choon H.
    Yun, Jae-Seung
    Kim, Won
    Kim, Dong Han
    Yoo, Soon Jib
    [J]. DIABETES, 2024, 73
  • [9] THE PREVALENCE OF MICROALBUMINURIA IN CHILDREN WITH TYPE 2 DIABETES MELLITUS (T2DM)
    Yafi, Michael
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2019, 104 : A250 - A250
  • [10] Regional effects of type 2 diabetes mellitus (T2DM) on neurodegeneration
    Moran, C.
    Phan, T. G.
    Beare, R. J.
    Chen, J.
    Blizzard, L.
    Venn, A.
    Greenaway, T.
    Munch, G.
    Forbes, J.
    Pearson, S.
    Srikanth, V
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2012, 7 : 20 - 20